Biomedical Engineering Reference
In-Depth Information
26
Wilhelm , C. , Billotey , C. , Roger , J. , Pons ,
J.N. , Bacri , J.C. and Gazeau , F. ( 2003 )
Intracellular uptake of anionic
superparamagnetic nanoparticles as a
function of their surface coating.
Biomaterials
,
24
( 6 ), 1001 - 11 .
27
Bulte , J.W. , Douglas , T. , Witwer , B. ,
Zhang , S.C. , Strable , E. , Lewis , B.K. ,
Zywicke , H. , Miller , B. , van Gelderen ,
P. , Moskowitz , B.M. , Duncan , I.D. and
Frank , J.A. ( 2001 ) Magnetodendrimers
allow endosomal magnetic labeling and
in vivo tracking of stem cells.
Nature
Biotechnology
,
19
( 12 ), 1141 - 7 .
28
Illum , L. , Church , A.E. , Butterworth ,
M.D. , Arien , A. , Whetstone , J. and
Davis , S.S. ( 2001 ) Development of
systems for targeting the regional
lymph nodes for diagnostic imaging:
in vivo behaviour of colloidal
PEG-coated magnetite nanospheres in
the rat following interstitial
administration .
Pharmaceutical Research
,
18
( 5 ), 640 - 5 .
29
Moffat , B.A. , Reddy , G.R. , McConville ,
P. , Hall , D.E. , Chenevert , T.L. ,
Kopelman , R.R. , Philbert , M. ,
Weissleder , R. , Rehemtulla , A. and Ross ,
B.D. ( 2003 ) A novel polyacrylamide
magnetic nanoparticle contrast agent for
molecular imaging using MRI.
Molecular
Imaging
,
2
( 4 ), 324 - 32 .
30
Kellar , K.E. , Fujii , D.K. , Gunther , W.H. ,
Briley - Saebo , K. , Bjornerud , A. , Spiller ,
M. and Koenig , S.H. ( 2000 ) NC100150
injection, a preparation of optimized
iron oxide nanoparticles for positive-
contrast MR angiography.
Journal of
Magnetic Resonance Imaging
,
11
( 5 ),
488 - 94 .
31
Kellar , K.E. , Fujii , D.K. , Gunther , W.H. ,
Briley - Saebo , K. , Spiller , M. and Koenig ,
S.H. ( 1999 ) ' NC100150 ' , a preparation of
iron oxide nanoparticles ideal for
positive - contrast MR angiography .
Magma
,
8
( 3 ), 207 - 13 .
32
Portet , D. , Denizot , B. , Rump , E. ,
Lejeune , J.J. and Jallet , P. ( 2001 )
Nonpolymeric coatings of iron oxide
colloids for biological use as magnetic
resonance imaging contrast agents.
Journal of Colloid and Interface Science
,
238
( 1 ), 37 - 42 .
33
Stark , D.D. , Weissleder , R. , Elizondo , G. ,
Hahn , P.F. , Saini , S. , Todd , L.E. ,
Wittenberg , J. and Ferrucci , J.T. ( 1988 )
Superparamagnetic iron oxide: clinical
application as a contrast agent for MR
imaging of the liver.
Radiology
,
168
( 2 ),
297 - 301 .
34
Weissleder , R. and Stark , D.D. ( 1989 )
Magnetic resonance imaging of the liver.
Magnetic Resonance Quarterly
,
5
( 2 ),
97 - 121 .
35
Weissleder , R. and Stark , D.D. ( 1989 )
Magnetic resonance imaging of liver
tumors .
Seminars in Ultrasound, CT, and
MR
,
10
( 1 ), 63 - 77 .
36
Weissleder , R. , Stark , D.D. , Engelstad ,
B.L. , Bacon , B.R. , Compton , C.C. , White ,
D.L. , Jacobs , P. and Lewis , J. ( 1989 )
Superparamagnetic iron oxide:
pharmacokinetics and toxicity.
American
Journal of Roentgenology
,
152
( 1 ), 167 - 73 .
37
Jung , C.W. ( 1995 ) Surface properties of
superparamagnetic iron oxide MR
contrast agents: ferumoxides,
ferumoxtran, ferumoxsil.
Magnetic
Resonance Imaging
,
13
( 5 ), 675 - 91 .
38
Taupitz , M. , Wagner , S. , Schnorr , J. ,
Kravec , I. , Pilgrimm , H. , Bergmann -
Fritsch , H. and Hamm , B. ( 2004 )
Phase I clinical evaluation of citrate-
coated monocrystalline very small
superparamagnetic iron oxide particles
as a new contrast medium for magnetic
resonance imaging.
Investigative
Radiology
,
39
( 7 ), 394 - 405 .
39
Ferrari , M. ( 2005 ) Cancer
nanotechnology: opportunities and
challenges .
Nature Reviews. Cancer
,
5
( 3 ),
161 - 71 .
40
Harisinghani , M.G. , Barentsz , J. , Hahn ,
P.F. , Deserno , W.M. , Tabatabaei , S. ,
van de Kaa , C.H. , de la Rosette , J. and
Weissleder , R. ( 2003 ) Noninvasive
detection of clinically occult lymph-node
metastases in prostate cancer.
The New
England Journal of Medicine
,
348
( 25 ),
2491 - 9 .
41
Harisinghani , M.G. and Weissleder , R.
( 2004 ) Sensitive, noninvasive detection
of lymph node metastases.
PLoS
Medicine
,
1
( 3 ), e 66 .
42
Enochs , W.S. , Harsh , G. , Hochberg , F.
and Weissleder , R. ( 1999 ) Improved
